Pharmaceutical

Nearly 1 in 10 teens globally have used ‘budget Ozempic’ laxatives and other risky weight loss products, per study

Nearly 1 in 10 teens globally have used ‘budget Ozempic...

Jan 10, 2024

Nearly 1 in 10 adolescents have used non-prescription weight loss products, acco...

STAT+: Pharmalittle: We’re reading about Sanofi’s Olympics bet, Singulair problems, and more

STAT+: Pharmalittle: We’re reading about Sanofi’s Olymp...

Jan 10, 2024

A 2020 FDA warning on the labeling that Singulair could cause aggression, agitat...

Advocates expect Supreme Court Idaho abortion decision to fuel efforts to further restrict access

Advocates expect Supreme Court Idaho abortion decision ...

Jan 10, 2024

Activists on both sides of the abortion debate said they anticipate ongoing effo...

STAT+: Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition

STAT+: Bayer’s promising menopause drug trial results h...

Jan 10, 2024

Bayer may soon join Astellas in offering an effective non-hormonal treatment for...

Opinion: Preventing health care violence in the ER requires moving from safety to security

Opinion: Preventing health care violence in the ER requ...

Jan 10, 2024

Health care workers facing violence in the ER need more than just safety — they ...

STAT+: Morgan Health wants you to know it’s still here

STAT+: Morgan Health wants you to know it’s still here

Jan 10, 2024

JPMorgan's business unit Morgan Health, started to control its health care costs...

JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far

JPM Day 2 has arrived. Here are the can’t-miss moments ...

Jan 10, 2024

In honor of JPM Week, you’re reading a special edition of our biotech newsletter...

STAT+: FDA’s Peter Marks seems inclined to grant full approval to Sarepta’s Duchenne gene therapy

STAT+: FDA’s Peter Marks seems inclined to grant full a...

Jan 10, 2024

The FDA's Peter Marks joined STAT for an interview about accelerated approval an...

Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one

Anthony Fauci talked Covid in Congress in a nine-hour, ...

Jan 10, 2024

Anthony Fauci spent nine hours on Capitol Hill yesterday, talking Covid behind c...

STAT+: Pharmalittle: We’re reading about a GSK deal, a probe into inhaler prices, and more

STAT+: Pharmalittle: We’re reading about a GSK deal, a ...

Jan 10, 2024

GSK will purchase the asthma drug developer Aiolos Bio for $1 billion upfront, t...

STAT+: Nvidia says a biological revolution is happening now. But is it?

STAT+: Nvidia says a biological revolution is happening...

Jan 10, 2024

Is now the moment when drug development, which for years has only gotten more di...

STAT+: JPM 2024: FogPharma’s new CEO, Mathai Mammen, unveils ‘contrarian’ plan in oncology

STAT+: JPM 2024: FogPharma’s new CEO, Mathai Mammen, un...

Jan 10, 2024

FogPharma CEO Mathai Mammen is taking the stage at #JPM24 Tuesday for what he’s ...

STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution

STAT+: Doudna institute hatches plan to ‘cure hundreds ...

Jan 10, 2024

The economics of CRISPR don't currently work for very rare diseases. The Doudna ...

HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy

HHS’s Xavier Becerra, once an ‘invisible’ secretary, is...

Jan 10, 2024

Health secretary Xavier Becerra, once ‘invisible,’ is finally making inroads wit...

AUR-101 by Aurigene Oncology for Psoriatic Arthritis: Likelihood of Approval

AUR-101 by Aurigene Oncology for Psoriatic Arthritis: L...

Jan 9, 2024

AUR-101 is under clinical development by Aurigene Oncology and currently in Phas...

Subasumstat by Takeda Pharmaceutical for Relapsed Multiple Myeloma: Likelihood of Approval

Subasumstat by Takeda Pharmaceutical for Relapsed Multi...

Jan 9, 2024

Subasumstat is under clinical development by Takeda Pharmaceutical and currently...